Institute for Clinical & Economic Review Issues Evidence Report Entitled 'Oral and Monoclonal Antibody Treatments for Relapsing Forms of Multiple Sclerosis'

Press/Media: Expert Comment

PeriodJan 2 2023

Media coverage

1

Media coverage

  • TitleInstitute for Clinical & Economic Review Issues Evidence Report Entitled 'Oral and Monoclonal Antibody Treatments for Relapsing Forms of Multiple Sclerosis'
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date1/2/23
    PersonsDenver Whittington